MRX CEO Ian Lowitt Sells Shares Worth $2.32 Million
Ian Lowitt, CEO of MRX, sold 37,143 shares in a planned transaction.
Key Points
- Ian Lowitt, CEO of MRX, sold 37,143 shares on June 12, 2026, for about $2.32 million.
- Shares of MRX traded near $62.50, with notable institutional activity including BlackRock and FMR LLC.
- Analysts like TD Cowen and Barclays maintain 'buy' ratings with targets up to $75.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Ian Lowitt, the Chief Executive Officer of MRX, sold 37,143 shares of the company on June 12, 2026. The transaction, which was planned, amounted to approximately $2.32 million, with an average sale price of $62.37 per share.
Insider Buying and Selling at Marex Group Limited
Several insiders at MRX have been active recently. On June 15, 2026, Paolo Tonucci, Chief Strategist and CEO of Capital Markets, sold 16,666 shares at an average price of $62.46 per share in a planned transaction. On June 9, 2026, other insiders, including Robert Mark Pickering, Sarah Ing, John Pietrowicz, and Linda Kristine Myers, each bought 2,070 shares in unplanned transactions.
Other Institutional Activity in MRX
Institutional investors have been adjusting their positions in MRX. BlackRock, Inc. increased its holdings by 422,791 shares, bringing its total to 4,389,325 shares valued at about $195.68 million. FMR LLC made a significant addition of 2,147,113 shares, ending with 3,481,911 shares worth approximately $155.22 million. In contrast, Loomis Sayles & Co L P slightly reduced its position by 16,881 shares, holding 1,918,622 shares valued at $85.53 million.
Marex Group Limited Stock Down 14.2%
Shares of MRX traded near $62.50. The stock has seen various institutional activities and insider transactions. Analysts continue to show interest, with several maintaining 'buy' ratings and target prices that suggest potential growth.
Analysts Set New Price Targets
Analysts remain optimistic about MRX. On June 8, 2026, TD Cowen maintained its 'buy' rating, setting a price target of $75.00. Barclays also maintained a 'buy' rating with a $60.00 target on May 11, 2026. The consensus among analysts is a 'buy' recommendation, with an average target price suggesting further upside.
Bottom Line
Ian Lowitt's recent sale of MRX shares is part of a planned transaction, reflecting personal financial management rather than a lack of confidence in the company. Institutional investors continue to show interest in MRX, with notable changes in positions. Analysts remain positive, maintaining 'buy' ratings with targets indicating potential growth. As always, these insights are based on past filings and reports and may not reflect the current market position.
Get Marex Group Limited alerts
New 13F filings, insider trades, and analyst moves on $MRX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.